Altered norepinephrine metabolism, following experimental spinal cord injury. 2. Protection against traumatic spinal cord hemorrhagic necrosis by norepinephrine synthesis blockade with alpha methyl tyrosine.
D000818:Animals; D002415:Cats; D006470:Hemorrhage / Q000188:drug therapy; D008781:Methyltyrosines / Q000627:therapeutic use*; D009336:Necrosis / Q000188:drug therapy; D009638:Norepinephrine / Q000096:biosynthesis / Q000378:metabolism*; D013116:Spinal Cord / Q000473:pathology; D013119:Spinal Cord Injuries / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors
D008781:Methyltyrosines; D014446:Tyrosine 3-Monooxygenase; D009638:Norepinephrine